Nazione: Australia
Lingua: inglese
Fonte: Department of Health (Therapeutic Goods Administration)
amitriptyline hydrochloride, Quantity: 25 mg
Ipca Pharma (Australia) Pty Ltd
amitriptyline hydrochloride
Tablet
Excipient Ingredients: lactose monohydrate; crospovidone; macrogol 6000; quinoline yellow aluminium lake; maize starch; purified talc; hypromellose; titanium dioxide; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose
Oral
100
(S4) Prescription Only Medicine
For the treatment of major depression. Amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,Nocturnal enuresis where organic pathology has been excluded.
Visual Identification: Yellow colour, circular, biconvex, film coated tablets with 'IA' over '25' debossed on one side and plain on the other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 12 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2014-08-22